West Nile virus infections projected from blood donor screening data, United States, 2003 - Wikidata - thesis-toulmin - TriplyDB

West Nile virus infections projected from blood donor screening data, United States, 2003

West Nile virus infections projected from blood donor screening data, United States, 2003

http://www.wikidata.org/entity/Q31041026

about

Prior exposure to uninfected mosquitoes enhances mortality in naturally-transmitted West Nile virus infection West Nile Virus in Europe and Safety of Blood Transfusion High Incidence of Chikungunya Virus and Frequency of Viremic Blood Donations during Epidemic, Puerto Rico, USA, 2014 Pathogenesis of West Nile Virus Infection: a Balance between Virulence, Innate and Adaptive Immunity, and Viral Evasion Tregs control the development of symptomatic West Nile virus infection in humans and mice The global ecology and epidemiology of West Nile virus Interferon regulatory factor-1 (IRF-1) shapes both innate and CD8(+) T cell immune responses against West Nile virus infection Genetic Variability of West Nile Virus in U.S. Blood Donors from the 2012 Epidemic Season The interferon-inducible gene viperin restricts West Nile virus pathogenesis Chemokine Receptor Ccr7 Restricts Fatal West Nile Virus Encephalitis Use of Blood Donor Screening Data to Estimate Zika Virus Incidence, Puerto Rico, April-August 2016 Emerging viral threats to the Australian blood supply.Persistence of West Nile virus in the central nervous system and periphery of mice West Nile virus neuroinvasive disease: neurological manifestations and prospective longitudinal outcomes.West Nile virus infection among the homeless, Houston, Texas.Effect of aerial insecticide spraying on West Nile virus disease--north-central Texas, 2012.West Nile virus emergence and persistence in Los Angeles, California, 2003-2008 PCR-based pooling of dried blood spots for detection of malaria parasites: optimization and application to a cohort of Ugandan children West nile virus and other arboviral diseases - United States, 2013.West Nile virus infection incidence based on donated blood samples and neuroinvasive disease reports, Northern Texas, USA, 2012.The effect of riboflavin and ultraviolet light on the infectivity of arboviruses.Meteorological conditions associated with increased incidence of West Nile virus disease in the United States, 2004-2012.Neuroinvasive disease and West Nile virus infection, North Dakota, USA, 1999-2008 Economic cost analysis of West Nile virus outbreak, Sacramento County, California, USA, 2005.Comparison of enzootic risk measures for predicting West Nile disease, Los Angeles, California, USA, 2004-2010.The National Heart, Lung, and Blood Institute retrovirus epidemiology donor studies (Retrovirus Epidemiology Donor Study and Retrovirus Epidemiology Donor Study-II): twenty years of research to advance blood product safety and availability.BMI and obesity in US blood donors: a potential public health role for the blood centre.Mapping and analysis of West Nile virus-specific monoclonal antibodies: prospects for vaccine development.Emerging infectious agents and the nation's blood supply: responding to potential threats in the 21st century Duration of Dengue Viremia in Blood Donors and Relationships Between Donor Viremia, Infection Incidence and Clinical Case Reports During a Large Epidemic.A role for Ifit2 in restricting West Nile virus infection in the brain The complex epidemiological scenario of West Nile virus in Italy.West Nile virus in the transfusion setting with a special focus on Italian preventive measures adopted in 2008-2012 and their impact on blood safety Correlation of West Nile Virus Incidence in Donated Blood with West Nile Neuroinvasive Disease Rates, United States, 2010-2012.Vaccines and immunotherapeutics for the prevention and treatment of infections with West Nile virus.Immune responses to West Nile virus infection in the central nervous system.Neuroinvasive arboviral disease in the United States: 2003 to 2012.Determining the rate of underrecognition of West Nile virus neurologic disease in the province of Quebec in 2012.West Nile Virus and Other Nationally Notifiable Arboviral Diseases - United States, 2015.A short N-terminal peptide motif on flavivirus nonstructural protein NS1 modulates cellular targeting and immune recognition.

P2860

Q21144412-493DE8F3-7C1A-40A3-9253-B3BE0DCF98BC Q26741185-7D809FD0-86C3-4474-B3E7-E5A3A4017B2C Q27468998-3E2AC5E1-CA46-44EE-BCC2-68AC2B43F1FC Q27477543-D1E7ECC6-8917-4837-8AB2-EFD3CF17422F Q27490259-41049F1B-2472-4CFD-9E3F-7313918CB491 Q28083311-D8620D15-AF42-4569-BFC3-A787A32C3433 Q28508364-CDB2B67B-2BA5-410C-8653-9AA8A189BF9D Q28552101-087FEC5A-2E6B-4C05-AF31-958F925E1C29 Q28594932-F1ADFFFA-7D25-4EC0-B8D8-4B9BECB76ED0 Q29198018-B93FB5DA-87F7-4E86-96DE-2F290E57D526 Q31171160-720787AE-1C13-45C8-AEC7-EF4247432A9A Q33368262-26D77EDE-446B-41EF-B919-493918717864 Q33586206-3234FB15-1FF3-4203-98F0-4D0040F45D2D Q33610392-E247DFAD-5441-4453-95FE-9ADECE4CAE77 Q33776727-A76BFE3A-750E-4BDD-9D76-402D5059721C Q34015866-316FD5B1-4B0F-44F5-8FCA-DBECBCAD8971 Q34024905-C0946A5D-3708-4DA0-B73C-449E0680026A Q34190509-02ACA047-6E00-407B-AE25-C4F8311CE234 Q34425452-A050081B-737C-468C-AD54-812ECD9325F4 Q35229705-7CE1C35F-6B05-4B48-ADCA-881D454D6FAC Q35394095-DF86E55C-1A6E-4EF0-9993-B82FED80D0EF Q35590668-C9CE9EE9-C310-4F3A-8218-0893079CB851 Q35844722-4970A283-1CEA-4402-A941-573AB74F8B7F Q35877366-7C11C6FE-5A0A-4428-A1C6-EE04B80C62F8 Q36148021-59D0BF68-4404-413B-903E-A37E4217250D Q36252455-DCE56481-BDC1-47A2-A18A-D2BBE31383F0 Q36456836-67C19760-EDB3-43F8-8E2B-906F13DF6212 Q36780133-CCE0742F-40F8-4A2A-B4A3-49A48CD26B3F Q36817997-3E3CCA2A-15A3-4779-975B-7402E11DEE06 Q37003076-E875D4C1-EDF4-44BB-9EB5-95D9DB06E675 Q37036707-7C132E8F-7AC0-4ADC-9C92-82C7C62679A0 Q37295897-481762AF-A933-4E30-820F-4188CFAF129F Q37306783-8CF827E3-C419-459C-A9E4-5887525F34D5 Q37664406-62A91311-DC29-4973-BCAA-0144ABB1CAAB Q37842337-FCF56150-7636-4D1D-B602-C7E674AD463C Q38068093-F9B966B5-0CC5-4D30-B520-21FDD11FE62F Q38239006-0113F7D2-5F32-4B8D-B6D8-8D0723D6D155 Q38903494-E1BFB0ED-CD65-4B45-8138-8326879A0F6E Q39012426-54C0BA02-9D32-4926-843F-4B1A31AEDBB9 Q39686453-51EB504A-BA58-4917-95CE-5F506706C8DD

P2860

West Nile virus infections projected from blood donor screening data, United States, 2003

http://www.wikidata.org/entity/Q31041026

description

2006 nî lūn-bûn

@nan

2006 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի մարտին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

West Nile virus infections projected from blood donor screening data, United States, 2003

@ast

West Nile virus infections projected from blood donor screening data, United States, 2003

@en

type

label

West Nile virus infections projected from blood donor screening data, United States, 2003

@ast

West Nile virus infections projected from blood donor screening data, United States, 2003

@en

prefLabel

West Nile virus infections projected from blood donor screening data, United States, 2003

@ast

West Nile virus infections projected from blood donor screening data, United States, 2003

@en

P1433

Q31041026-EC4DF9F8-5ADC-4BD0-8918-7B7E3B190BF1

P1476

Q31041026-A4898C9C-7F71-4CEC-937E-A493E10AF5E0

P2093

Q31041026-1BF42661-63A1-4B23-A36D-D0A753D6E4BE

Q31041026-1D30A3C0-AFA8-4D44-A15B-2360EE8D6846

Q31041026-56C56722-41F8-413C-A075-F957C4A07567

Q31041026-79814C50-4653-4D89-881D-C49E88EBF9A1

Q31041026-8C7E8687-B0E6-46A0-B832-95458DB2024B

Q31041026-A26CEB4B-B220-4576-800D-5E47EE1EDE7D

Q31041026-C9B29048-DD3A-4848-AE5C-92B2BBA3748B

Q31041026-D72B7408-3A2D-46E7-862A-14D92413ED32

Q31041026-DBD43CCE-A5E2-415B-B603-76ADB63EC299

P2860

Q31041026-06E89183-9ED7-40A5-B8BD-BC664DBCBF4F

Q31041026-140146DD-C551-4CC1-BED1-5F591E230018

Q31041026-1426BE3E-47D3-4BBD-B37D-B31036261A29

Q31041026-1821C52D-4786-4773-8FCD-FA4493E044DF

Q31041026-1D18E087-55F1-4EE5-B53C-B77DC9084737

Q31041026-55466D3F-F81F-4FEB-90CF-18785D42AE10

Q31041026-5EB89E52-500B-4403-8ECA-6558938312A8

Q31041026-6069ADFF-FE33-47CF-9182-6409F3C200BE

Q31041026-6D9C038D-A88F-474A-BD12-A19F066E7A00

Q31041026-6D9DA288-E933-4C6B-B322-9E78122CF1E6

P304

Q31041026-C64D4A7A-BD32-4DB0-B4CD-2BAF2370EAB5

P31

Q31041026-DB17596E-2F1A-4E51-B185-0517B7B6DB7C

P356

Q31041026-F450EDD0-1A68-40D1-8A4E-D8DF07B34E22

P433

Q31041026-BD309552-9DC2-4D4F-B0CD-BABFAF252C8F

P478

Q31041026-9AB79E69-132B-4876-B779-7689CC5FAAA4

P50

Q31041026-186EEB02-69E4-4E3F-B202-80AEAA173003

Q31041026-317D231B-D744-41A1-AA90-E4600D9954FA

Q31041026-F2EB89E2-9664-4737-BD64-2EFBE2AED891

P577

Q31041026-EA595909-B247-4319-8FA5-B0978EA3B7E7

P5875

Q31041026-BD333E13-049A-4E7E-8704-9A4042BA6DC7

P698

Q31041026-D38C355B-88C0-42EF-91A9-34BEC6DDCD59

P921

Q31041026-316801C4-1249-4B12-9C55-56E078782788

Q31041026-3AC5917E-D38E-43D1-AA60-76ED550BA21B

P932

Q31041026-6045AB88-81B9-43E2-ABEB-A494DE099753

P356

P1433

Emerging Infectious Diseases

P1476

West Nile virus infections projected from blood donor screening data, United States, 2003

@en

P2093

Brian Custer

http://www.w3.org/2001/XMLSchema#string

Celso Bianco

http://www.w3.org/2001/XMLSchema#string

David J Wright

http://www.w3.org/2001/XMLSchema#string

George Nemo

http://www.w3.org/2001/XMLSchema#string

Gregory Foster

http://www.w3.org/2001/XMLSchema#string

Harry E Prince

http://www.w3.org/2001/XMLSchema#string

Leslie H Tobler

http://www.w3.org/2001/XMLSchema#string

Simone A Glynn

http://www.w3.org/2001/XMLSchema#string

Steven H Kleinman

http://www.w3.org/2001/XMLSchema#string

P2860

Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey

Persistence of virus-reactive serum immunoglobulin m antibody in confirmed west nile virus encephalitis cases

Development and persistence of West Nile virus-specific immunoglobulin M (IgM), IgA, and IgG in viremic blood donors.

Use of immunoglobulin m cross-reactions in differential diagnosis of human flaviviral encephalitis infections in the United States

Detection of West Nile Virus (WNV)-Specific Immunoglobulin M in a Reference Laboratory Setting during the 2002 WNV Season in the United States

Screening the blood supply for West Nile virus RNA by nucleic acid amplification testing

West Nile encephalitis epidemic in southeastern Romania

West Nile virus: a primer for the clinician

Triggers for switching from minipool testing by nucleic acid technology to individual-donation nucleic acid testing for West Nile virus: analysis of 2003 data to inform 2004 decision making.

Update: West Nile virus screening of blood donations and transfusion-associated transmission--United States, 2003.

P304

395-402

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3201/EID1205.051287

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Lyle R. Petersen

Susan L Stramer

Michael P. Busch

P577

2006-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7076409

http://www.w3.org/2001/XMLSchema#string

P698

16704775

http://www.w3.org/2001/XMLSchema#string

P921

West Nile virus

Ameeriga Ütisriigiq

P932

3291460

http://www.w3.org/2001/XMLSchema#string